Showing results (11-20 of 211) with videos related to
Sort By:
Pageof 22
Current Opinion in Psychiatry|February 6, 2019
Caregivers of individuals with schizophrenia: who are they and what are their challenges?Saher Hoda Kamil, Dawn I VelliganJournal of Psychiatric Research|February 23, 2017
Leukocyte telomere length in Hispanic schizophrenia patients under treatment with olanzapineNancy Monroy-Jaramillo, Yaneth Rodríguez-Agudelo, Luis Carlos Aviña-Cervantes, et al.World Journal of Psychiatry|January 8, 2016
Conceptualization and treatment of negative symptoms in schizophreniaSonali Sarkar, Kiley Hillner, Dawn I VelliganSchizophrenia Bulletin|May 12, 2007
Performance-based measures of functional skills: usefulness in clinical treatment studiesPhilip D Harvey, Dawn I Velligan, Alan S BellackPsychiatric Services (Washington, D.C.)|January 15, 2026
The Role of Cognitive Screening in Community Mental Health Clinics Serving People With SchizophreniaDawn I Velligan, Alice Saperstein, Lilyana Brodrick, et al.Schizophrenia Bulletin|April 28, 2006
Cognitive rehabilitation for schizophrenia and the putative role of motivation and expectanciesDawn I Velligan, Robert S Kern, James M GoldPsychiatric Services (Washington, D.C.)|October 17, 2014
Outcomes of medicaid beneficiaries with schizophrenia receiving clozapine only or antipsychotic combinationsDawn I Velligan, Cathy Carroll, Maureen J Lage, et al.Frontiers in Psychiatry|September 26, 2019
Caregiver Burdens Associated With Treatment-Resistant Schizophrenia: A Quantitative Caregiver Survey of Experiences, Attitudes, and PerceptionsDawn I Velligan, Cecilia Brain, Laëtitia Bouérat Duvold, et al.Psychiatry Research|November 22, 2012
A qualitative assessment of cross-cultural adaptation of intermediate measures for schizophrenia in multisite international studiesJodi M Gonzalez, Maureen Rubin, Megan M Fredrick, et al.Expert Review of Clinical Pharmacology|December 24, 2015
Methodological issues associated with preclinical drug development and increased placebo effects in schizophrenia clinical trialsMatt A Brown, Ram J Bishnoi, Sara Dholakia, et al.Pageof 22